| Mr John Brett Dietze, MD | |
|
2602 Saint Michael Dr Ste 302b, Texarkana, TX 75503-5228 | |
| (903) 794-4196 | |
| (903) 614-5169 |
| Full Name | Mr John Brett Dietze |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 30 Years |
| Location | 2602 Saint Michael Dr Ste 302b, Texarkana, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588665319 | NPI | - | NPPES |
| 1G1885 | Other | TX | MEDICARE |
| 141100101 | Other | INDIGENT HEALTH CARE | |
| 18796000000 | Other | AR | QUALCHOICE OF ARKANSAS |
| 98601 | Other | TX | COLLUM & CARNEY CLINIC |
| 98601 | Other | AR | BLUE CROSS |
| 179117500 | Other | US DEPT OF LABOR | |
| 1871793307 | Other | TX | CIGNA DME |
| 8A0896 | Other | TX | BLUE CROSS |
| 140006859 | Other | TX | RAILROAD MEDICARE |
| 141100101 | Medicaid | TX | |
| 142238001 | Medicaid | AR | |
| 200023040A | Medicaid | OK | |
| 5575000001 | Other | TX | CIGNA GOVERNMENT SERVICES |
| MDK2152 | Other | TX | WORKERS' COMPENSATION |
| 98601 | Other | FIRST PYRAMID LIFE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | K2152 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Health Center | Waco, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ir Rehab, P.c. | 1153453691 | 121 |
| Providence Health Alliance | 6305731068 | 129 |
News Archive
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.
A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) - a blood clot in the lung - experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.
On August 12th at 2:00 p.m. ET, Mandy Moore joins Nothing But Nets™ and PSI for a video townhall on malaria in Africa, broadcast on Facebook®. The video conferencing service will be provided by VSee Lab, Inc. and Ustream, and the event is hosted by Derrick Ashong, one of Katalyst Media's Social Media Envoys. This is an opportunity to question Mandy Moore and learn about sending nets and saving lives. Become a fan of Nothing But Nets on Facebook and join the discussion.
The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.
› Verified 9 days ago
| Entity Name | Christus Trinity Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285684225 PECOS PAC ID: 3072426741 Enrollment ID: O20031204001091 |
News Archive
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.
A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) - a blood clot in the lung - experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.
On August 12th at 2:00 p.m. ET, Mandy Moore joins Nothing But Nets™ and PSI for a video townhall on malaria in Africa, broadcast on Facebook®. The video conferencing service will be provided by VSee Lab, Inc. and Ustream, and the event is hosted by Derrick Ashong, one of Katalyst Media's Social Media Envoys. This is an opportunity to question Mandy Moore and learn about sending nets and saving lives. Become a fan of Nothing But Nets on Facebook and join the discussion.
The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.
› Verified 9 days ago
| Entity Name | Providence Health Alliance |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932210838 PECOS PAC ID: 6305731068 Enrollment ID: O20040220000307 |
News Archive
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.
A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) - a blood clot in the lung - experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.
On August 12th at 2:00 p.m. ET, Mandy Moore joins Nothing But Nets™ and PSI for a video townhall on malaria in Africa, broadcast on Facebook®. The video conferencing service will be provided by VSee Lab, Inc. and Ustream, and the event is hosted by Derrick Ashong, one of Katalyst Media's Social Media Envoys. This is an opportunity to question Mandy Moore and learn about sending nets and saving lives. Become a fan of Nothing But Nets on Facebook and join the discussion.
The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.
› Verified 9 days ago
| Entity Name | C H Wilkinson Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457382947 PECOS PAC ID: 8921919580 Enrollment ID: O20041203000584 |
News Archive
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.
A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) - a blood clot in the lung - experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.
On August 12th at 2:00 p.m. ET, Mandy Moore joins Nothing But Nets™ and PSI for a video townhall on malaria in Africa, broadcast on Facebook®. The video conferencing service will be provided by VSee Lab, Inc. and Ustream, and the event is hosted by Derrick Ashong, one of Katalyst Media's Social Media Envoys. This is an opportunity to question Mandy Moore and learn about sending nets and saving lives. Become a fan of Nothing But Nets on Facebook and join the discussion.
The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr John Brett Dietze, MD P O Box 9600, Dept 09-019, Texarkana, TX 75505-9600 Ph: (903) 794-4196 | Mr John Brett Dietze, MD 2602 Saint Michael Dr Ste 302b, Texarkana, TX 75503-5228 Ph: (903) 794-4196 |
News Archive
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.
A multi-centre clinical study, led by Dr. Susan Kahn at the Jewish General Hospital (JGH), determined that nearly half of the patients who suffer a pulmonary embolism (PE) - a blood clot in the lung - experience long term limitations to their capacity for physical activity and that this had a negative impact on their quality of life.
On August 12th at 2:00 p.m. ET, Mandy Moore joins Nothing But Nets™ and PSI for a video townhall on malaria in Africa, broadcast on Facebook®. The video conferencing service will be provided by VSee Lab, Inc. and Ustream, and the event is hosted by Derrick Ashong, one of Katalyst Media's Social Media Envoys. This is an opportunity to question Mandy Moore and learn about sending nets and saving lives. Become a fan of Nothing But Nets on Facebook and join the discussion.
The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.
› Verified 9 days ago
Dr. Jason Robert Hall, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2602 Saint Michael Dr Ste 302b, Texarkana, TX 75503 Phone: 903-614-5180 Fax: 903-614-5166 | |
Ricardo Cortez, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2602 Saint Michael Dr, Texarkana, TX 75503 Phone: 903-794-4196 | |
Mr. Freddie L Contreras, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1002 Texas Blvd, Ste 406, Texarkana, TX 75501 Phone: 903-794-4196 Fax: 903-792-7408 | |
Brian Keith Willis, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1002 Texas Blvd Ste 406, Texarkana, TX 75501 Phone: 903-794-4196 Fax: 903-792-7408 |